TLX

Telix Pharmaceuticals Limited

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$9.36

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %17 / %30

Non-compliant assets / Total market cap %0 / %30

Non-compliant revenue / Total income %0.7 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions.

Website

Analysis (Turkish): TLX Hissesi Caiz mi, Helal mi? Telix Pharmaceuticals Limited Katılım Analizi